Joel Aaron Brochstein MD
Associate Professor, Pediatrics, Hofstra North Shore-LIJ
Join to view full profile
269-01 76th AvenueSuite 255New Hyde Park, NY 11040
Phone+1 718-470-3460
Fax+1 718-343-4642
Dr. Brochstein is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
New York Presbyterian Hospital (Cornell Campus)Residency, Pediatrics, 1980 - 1983- New York Presbyterian Hospital (Cornell Campus)Fellowship, Pediatric Hematology/Oncology, 1979 - 1980
- New York Presbyterian Hospital (Cornell Campus)Residency, Pediatrics, 1977 - 1979
Weill Cornell MedicineClass of 1977
Certifications & Licensure
NY State Medical License 1978 - 2027
NJ State Medical License 1981 - 2011
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts TouchWorks EHR (Complete), Allscripts, 2016
- Fellow (FAAP) American Academy of Pediatrics
Clinical Trials
- Cord Blood Transplantation for Sickle Cell Anemia and Thalassemia
- Comparison of Fluconazole vs Voriconazole to Treat Fungal Infections for Blood and Marrow Transplants (BMT CTN 0101)
- Peripheral Blood Stem Cell Transplant vs Bone Marrow Transplant in Individuals With Hematologic Cancers (BMT CTN 0201)
Publications & Presentations
PubMed
- 5 citationsLong-term outcomes after unrelated donor transplantation for severe sickle cell disease on the BMT CTN 0601 trial.Mary Eapen, Jianqun Kou, Martin Andreansky, Monica Bhatia, Joel Brochstein
American Journal of Hematology. 2024-04-01 - 22 citationsAllogeneic stem cell transplantation with omidubicel in sickle cell disease.Suhag Parikh, Joel A. Brochstein, Einat Galamidi, Aurelie Schwarzbach, Joanne Kurtzberg
Blood Advances. 2021-02-09 - 4 citationsTiming of Alemtuzumab With Respect to Day of Bone Marrow Infusion and its Effects Upon Engraftment and Graft-Versus-Host Disease in Patients With Sickle Cell Disease: ...Indira Sahdev, Joel A. Brochstein, Nan Werther, Jessica Stiles
Journal of Pediatric Hematology/oncology. 2020-11-01
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
